Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: A cohort study

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  De Goeij, Moniek C M ^a   Voormolen, Nora ^a   Halbesma, Nynke ^a   De Jager, Dinanda J ^a   Boeschoten, Elisabeth W ^b   Sijpkens, Yvo W J ^a,c   Dekker, Friedo W ^a   Grootendorst, Diana C ^a,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Hans Mak Institute   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d Kennemer Gasthuis   (Netherlands)

Author keywords

blood pressure; chronic kidney disease stages IV V; estimated glomerular filtration rate; pre dialysis care; renal replacement therapy

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT; RENAL REPLACEMENT THERAPY; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; TIME FACTORS;

EID: 80051493391     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-38     Document Type: Article

References (35)

1. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, van Lente F, Levey AS, JAMA 2007 298 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
2. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ, J Am Soc Nephrol 2005 16 3736 3741 10.1681/ASN.2005010112 16267160 (Pubitemid 46211296)
3. Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999. Stengel B, Billon S, van Dijk PC, Jager KJ, Dekker FW, Simpson K, Briggs JD, Nephrol Dial Transplant 2003 18 1824 1833 10.1093/ndt/gfg233 12937231 (Pubitemid 37098555)
4. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Kronborg J, Solbu M, Njølstad I, Toft I, Eriksen BO, Jenssen T, Nephrol Dial Transplant 2008 23 2818 2826 10.1093/ndt/gfn148 18400822
5. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, Szklo M, Brancati FL, Arch Intern Med 1999 159 1777 1783 10.1001/archinte.159.15.1777 10448782 (Pubitemid 29379142)
6. Glucose tolerance and age-associated decline in renal function of hypertensive patients. Ribstein J, du Cailar G, Mimran A, J Hypertens 2001 19 2257 2264 10.1097/00004872-200112000-00020 11725171 (Pubitemid 33135249)
7. Prospective study of progression of kidney dysfunction in community-dwelling older adults. Sesso R, Prado F, Vicioso B, Ramos LR, Nephrology (Carlton) 2008 13 99 103 10.1111/j.1440-1797.2008.00919.x (Pubitemid 351229632)
8. Temporal relation between blood pressure and serum creatinine in young adults from a biracial community: the Bogalusa Heart Study. Youssef AA, Srinivasan SR, Elkasabany A, Cruickshank JK, Berenson GS, Am J Hypertens 2000 13 770 775 10.1016/S0895-7061(00)00233-8 10933568 (Pubitemid 30608212)
9. Predictors of new-onset kidney disease in a community-based population. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D, JAMA 2004 291 844 850 10.1001/jama.291.7.844 14970063 (Pubitemid 38543772)
10. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A, Kidney Int 2007 71 159 166 10.1038/sj.ki.5002017 17136030 (Pubitemid 46094690)
11. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C, Arch Intern Med 2005 165 923 928 10.1001/archinte.165.8.923 15851645 (Pubitemid 40563240)
12. Comparison of the effect of blood pressure on the development of stroke, acute myocardial infarction, and end-stage renal disease. Iseki K, Kimura Y, Wakugami K, Okumura K, Muratani H, Ikemiya Y, Fukiyama K, Hypertens Res 2000 23 143 149 10.1291/hypres.23.143 10770261 (Pubitemid 30326238)
13. Blood pressure and end-stage renal disease in men. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J, N Engl J Med 1996 334 13 18 10.1056/NEJM199601043340103 7494564 (Pubitemid 26012498)
14. Blood pressure predicts risk of developing end-stage renal disease in men and women. Tozawa M, Iseki K, Iseki C, Kinjo K, Ikemiya Y, Takishita S, Hypertension 2003 41 1341 1345 10.1161/01.HYP.0000069699.92349.8C 12707291 (Pubitemid 36706087)
15. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 1 266 11904577
16. Progression of renal insufficiency: role of blood pressure. Brazy PC, Stead WW, Fitzwilliam JF, Kidney Int 1989 35 670 674 10.1038/ki.1989.37 2709671 (Pubitemid 19051768)
17. Analysis of factors influencing chronic renal failure progression. Jovanovic DB, Djukanovic L, Ren Fail 1999 21 177 187 10.3109/08860229909066982 10088178 (Pubitemid 29143818)
18. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group. Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A, Nephrol Dial Transplant 1996 11 461 467 8710157 (Pubitemid 26092784)
19. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS, Ann Intern Med 2005 142 342 351 15738453 (Pubitemid 40293407)
20. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004 43 1 290 15114537
21. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, JAMA 2003 289 2560 2572 10.1001/jama.289.19.2560 12748199 (Pubitemid 37430158)
22. Hypertension and coronary artery disease: a summary of the American Heart Association scientific statement. Rosendorff C, J Clin Hypertens (Greenwich) 2007 9 790 795 10.1111/j.1751-7176.2007.tb00006.x
23. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Ann Intern Med 1999 130 461 470 10075613 (Pubitemid 29135798)
24. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE, Kidney Int 1997 51 1908 1919 10.1038/ki.1997.260 9186882 (Pubitemid 27252762)
25. Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study Group. Beck GJ, Berg RL, Coggins CH, Gassman JJ, Hunsicker LG, Schluchter MD, Williams GW, Control Clin Trials 1991 12 566 586 10.1016/0197-2456(91)90069-X 1664792
26. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Levin A, Djurdjev O, Beaulieu M, Er L, Am J Kidney Dis 2008 52 661 671 10.1053/j.ajkd.2008.06.023 18805347
27. Intensive blood-pressure control in hypertensive chronic kidney disease. Appel LJ, Wright JT Jr, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X, N Engl J Med 2010 363 918 929 10.1056/NEJMoa0910975 20818902
28. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, N Engl J Med 1994 330 877 884 10.1056/NEJM199403313301301 8114857 (Pubitemid 24094966)
29. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG, JAMA 2002 288 2421 2431 10.1001/jama.288.19.2421 12435255 (Pubitemid 35340538)
30. MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. van Zuilen AD, Wetzels JF, Bots ML, van Blankestijn PJ, J Nephrol 2008 21 261 267 18587712
31. Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study. Nakayama M, Sato T, Sato H, Yamaguchi Y, Obara K, Kurihara I, Sato K, Hotta O, Seino J, Miyata M, Takeuchi K, Nakayama K, Matsushima M, Otaka T, Kinoshita Y, Taguma Y, Ito S, Clin Exp Nephrol 2010 14 333 339 10.1007/s10157-010-0295-y 20556461
32. Unreferred chronic kidney disease: a longitudinal study. John R, Webb M, Young A, Stevens PE, Am J Kidney Dis 2004 43 825 835 10.1053/j.ajkd.2003.12.046 15112173 (Pubitemid 38529620)
33. Endothelial dysfunction. Endemann DH, Schiffrin EL, J Am Soc Nephrol 2004 15 1983 1992 10.1097/01.ASN.0000132474.50966.DA 15284284 (Pubitemid 39031337)
34. Causes and consequences of increased arterial stiffness in chronic kidney disease patients. Gusbeth-Tatomir P, Covic A, Kidney Blood Press Res 2007 30 97 107 10.1159/000100905 17374960 (Pubitemid 46674914)
35. Pathophysiology of progressive nephropathies. Remuzzi G, Bertani T, N Engl J Med 1998 339 1448 1456 10.1056/NEJM199811123392007 9811921 (Pubitemid 28516069)